- Home
- DTST vs ANEB Comparison
DTST vs ANEB Comparison
Compare DTST & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- ANEB
- Stock Information
- Founded
- DTST 2001
- ANEB 2020
- Country
- DTST United States
- ANEB United States
- Employees
- DTST N/A
- ANEB N/A
- Industry
- DTST EDP Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- ANEB Health Care
- Exchange
- DTST Nasdaq
- ANEB Nasdaq
- Market Cap
- DTST 33.4M
- ANEB 39.0M
- IPO Year
- DTST N/A
- ANEB 2021
- Fundamental
- Price
- DTST $4.68
- ANEB $2.85
- Analyst Decision
- DTST
- ANEB Buy
- Analyst Count
- DTST 0
- ANEB 2
- Target Price
- DTST N/A
- ANEB $8.00
- AVG Volume (30 Days)
- DTST 984.8K
- ANEB 1.1M
- Earning Date
- DTST 08-14-2025
- ANEB 09-24-2025
- Dividend Yield
- DTST N/A
- ANEB N/A
- EPS Growth
- DTST N/A
- ANEB N/A
- EPS
- DTST 0.02
- ANEB N/A
- Revenue
- DTST $25,219,312.00
- ANEB N/A
- Revenue This Year
- DTST $12.57
- ANEB N/A
- Revenue Next Year
- DTST $9.29
- ANEB N/A
- P/E Ratio
- DTST $195.72
- ANEB N/A
- Revenue Growth
- DTST N/A
- ANEB N/A
- 52 Week Low
- DTST $2.93
- ANEB $0.80
- 52 Week High
- DTST $5.57
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- DTST 59.06
- ANEB 66.43
- Support Level
- DTST $4.61
- ANEB $1.53
- Resistance Level
- DTST $4.87
- ANEB $3.42
- Average True Range (ATR)
- DTST 0.34
- ANEB 0.20
- MACD
- DTST -0.01
- ANEB 0.05
- Stochastic Oscillator
- DTST 63.64
- ANEB 69.84
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.